Tag: Revance

All

Game On: Revance Therapeutics Initiates Phase 3 Trial of Topical Botox

Will Revance's RT001 be the first topically neurotoxin treatment?

Cosmetic Surgery Foundation Welcomes New Members to Industry Advisory Council
The Face: It’s Faux Tox Time
Revance Relocates from California to Tennessee
Long Shot: Revance’s RT002 May Banish Frown Lines for 7 Months
Aji Bio-Pharma and Revance in Manufacturing Deal for Anti-Wrinkle Rival to Botox
Hot Stuff: February 2015
Revance Therapeutics Provides Update on DaxibotulinumtoxinA for Injection Pre-Approval Inspection
As Revance Nears a Potential Launch for its Botox Rival, AbbVie Sues for Patent Infringement

All

AbbVie’s Botox Patent Lawsuit is ‘Very Unlikely to Derail’ Revance’s Rival Launch: Analysts

For a small company seeking to market a rival to a dominant brand, a patent lawsuit from a global pharma giant would seem to be a cause for concern. But Revance has a good chance of beating back AbbVie's recent patent case, one team of analysts figures, Fierce Pharma reports.